Krzysztof Piotr Malinowski

The indirect costs of psoriatic arthritis: systematic review and meta-analysis

The aim of this systematic review is to collect all current data on the indirect costs (IC) related to psoriatic arthritis (PsA). The search was conducted using MEDLINE (via PubMed), Embase and Centre for Reviews and Dissemination databases. We considered original studies, systematic reviews, economic evaluations, conference abstracts and posters. All collected data were recalculated to average annual cost per patient, expressed using the consumer price index for 2013 and converted to US dollars using purchasing power parity. Eight of the identified publications presented IC of PsA. Average annual IC per patient calculated using the friction cost approach range from US

Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis

1693.83 to

Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012–2014, a retrospective analysis

12,318.45, while using the human capital approach they range from US

The indirect costs of multiple sclerosis: systematic review and meta-analysis

1750.68 to

The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis

50,270.52. Result of the meta-analysis was a basis for calculating cost of work disability equaled US

Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012–2014

10,754.04 per patient per year in 2013 prices. This systematic review revealed a great economic burden of the disease to the society. A small number of studies on IC in PsA justify further investigations.

Health utility of patients with Crohn’s disease and ulcerative colitis: a systematic review and meta-analysis

The aim of this systematic review was to collect all current data on indirect costs related to inflammatory bowel disease as well as assessing homogeneity and comparability, and conducting a meta-analysis. Costs were collected using databases from Medline, Embase and Centre for Reviews and Dissemination databases, then average annual cost per patient was calculated and expressed in 2013-rate USD using the consumer price index and purchasing power parity (scenario 1) and then adjusted to specific gross domestic product (scenario 2) to make them comparable. The studies were then included in quantitative synthesis using the meta-analysis and bootstrap methods. This systematic review was carried out and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. From 18 publications, overall annual indirect costs per patient as a result of the quantitative synthesis among all studies eligible for meta-analysis ranged from US

Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes

2425.01–US

The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland

9622.15 depending on the scenario and model used for analysis. The cost of presenteeism was assessed in only two studies. Considering heterogeneity among all identified studies random-effect model presented the most accurate results of meta-analysis equal to US

Stenotic Bicuspid and Tricuspid Aortic Valves ― Micro-Computed Tomography and Biological Indices of Calcification ―

7189.27 and US